Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2233–2256 of 3,580 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: patch Clear all

Conditions: Lung Cancer, Lung Cancer Metastatic
Interventions: Porfimer Sodium, Fiber optic; Drug · Device
Lead sponsor: Concordia Laboratories Inc.; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 8
States / cities: Los Angeles, California • Denver, Colorado • Tampa, Florida + 5 more

Conditions: Prostate Cancer
Interventions: TRAQinform Theranostics; Device
Lead sponsor: AIQ Solutions; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: New York, New York • Houston, Texas

Conditions: Aortoiliac Occlusive Disease
Interventions: GORE VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX); Device
Lead sponsor: W.L.Gore & Associates; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 21
States / cities: Birmingham, Alabama • Fresno, California • Tampa, Florida + 18 more

Conditions: Parkinson Disease
Interventions: Intravenous Levodopa, Lisuride Transdermal System; Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 40 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer
Interventions: Bi-parametric MRI-based cascaded deep-learning AI algorithm; Device
Lead sponsor: University of Arkansas; Other
Eligibility: 40 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Smoking Behaviors
Interventions: Aim 1: Online survey, Eye Tracking Activity, Eye tracking survey, Online Experimental Marketplace (ETM), Aim 3 survey, Cognitive Interviews, Supplemental Aim 1 Interviews; Other · Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 16 Years to 28 Years
Enrollment: 658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Vitiligo
Interventions: Skinpen Precision System; Device
Lead sponsor: Crown Laboratories, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: CTCL/ Mycosis Fungoides, CTCL, Mycosis Fungoides, Cutaneous T Cell Lymphoma
Interventions: Hypericin, Placebo; Drug
Lead sponsor: Soligenix; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 17
States / cities: Phoenix, Arizona • Scottsdale, Arizona • San Diego, California + 14 more

Conditions: Pain, Needle Phobia
Interventions: EMLA Cream, Synera Patch; Drug · Combination Product
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 4 Years to 12 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Renal Stenting in the Treatment of Pts w/a High Grade Ostial Atherosclerotic Renal Lesion(s).
Interventions: Lumen Biomedical FiberNet Embolic Protection System; Device
Lead sponsor: VIVA Physicians; Other
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2008
U.S. locations: 1
States / cities: San Jose, California

Conditions: Hepatocellular Carcinoma
Interventions: Optical Molecular Imaging (OMI), Indocyanine Green (ICG), Electromagnetic Tracking; Device · Radiation
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma, Metastatic Bone Tumor, Bone Sarcoma
Interventions: Ascorbate; Drug
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Skin Cancer
Interventions: Lesion biopsy, DermaSensor Device Use; Procedure · Device
Lead sponsor: DermaSensor, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 1,028 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Brain Metastases, Adult
Interventions: Pre-operative Stereotactic Radiosurgery; Other
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Upper Gastrointestinal Hemorrhage
Interventions: Over-the-scope hemoclipping device, Standard endoscopic treatment; Device · Other
Lead sponsor: CURE Digestive Diseases Research Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Allergic Contact Dermatitis
Interventions: bacitracin (allergen); Drug
Lead sponsor: Mekos Laboratories AS; Industry
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Chlorhexidine Allergy, Infection, Rash
Interventions: Chlorhexidine gluconate; Drug
Lead sponsor: Celeste Chandonnet; Other
Eligibility: 36 Weeks to 48 Weeks
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Tobacco Use, Smoking Cessation, Smoking Behaviors, Nicotine Dependence, Nicotine Withdrawal
Interventions: Nicotine Replacement Therapy (NRT) Sampling, Practice Quitting (PQ) Counseling, Motivational Interviewing (MI) Counseling; Drug · Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Nicotine Dependence
Interventions: Aerobic Exercise, Counseling, Nicotine patch; Behavioral · Drug
Lead sponsor: Jasper A. Smits; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Syncope, Presyncope, Atrial Fibrillation, Supraventricular Tachycardia
Interventions: EKG Patch monitors (Zio and Carnation); Device
Lead sponsor: EvergreenHealth; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Kirkland, Washington

Conditions: Coronary Artery Disease (CAD)
Interventions: Orbital Atherectomy System (OAS), Rotablator Rotational Atherectomy System, Magnetic Resonance Imaging (MRI); Device · Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Actinic Keratoses
Interventions: 5% 5-fluorouracil (5-FU) powder, 5% 5-fluorouracil (5-FU) powder PLUS 15% Aluminum Chloride Hexahydrate (ACH); Drug
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Coronary Artery Disease, Coronary Stenosis, Atherosclerosis, STEMI, STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
Interventions: Coronary PCI guided by OCT, Coronary PCI guided by Angiography; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,487 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 42
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Burlingame, California + 37 more

Conditions: Herpes Zoster, Neuralgia, Pain, Peripheral Nervous System Diseases
Interventions: Capsaicin Dermal Patch; Drug
Lead sponsor: NeurogesX; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 19
States / cities: Mesa, Arizona • Peoria, Arizona • Phoenix, Arizona + 15 more

Search by objective public record fields.

Safety of PDT-Photofrin® Prior to Lung Surgery

Comprehensive Assessment of Cancer Theranostic Response

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Lisuride Patch to Treat Parkinson's Disease

AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions

C-FLASH (Cigarillo Flavor and Abuse Liability, Attention, and Substitution in youtH)

A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo

Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL

The Efficacy of EMLA Cream vs. Synera Patch for Pain Reduction During Venipuncture in Children

Safety & Performance Study of Lumen Biomedical's FiberNet Distal Protection System for the Treatment of Renal Artery Stenosis

Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

DermaSensor Study of Primary Care Physician Use of Elastic-Scattering Spectroscopy (ESS) on Skin Lesions Suggestive of Skin Cancer

A Phase II Study of Pre-Op SRS Followed by Surgical Resection for Brain Metastases

Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage

Clinical Evaluation of Bacitracin

Pilot Study: Safety of Chlorhexidine (CHG) Baths in Patients Less Than 2 Months of Age

Overcoming Nicotine Dependence to Enable Quitting

Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.

Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial

Comparison of Orbital Versus Rotational Atherectomy Effects On Coronary Microcirculation in PCI

Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia